TABLE 2. IR and 1H NMR Spectra of the Compounds Synthesized
IR spectrum
Com-
1Н NMR spectrum, δ, ppm (J, Hz)
(С=О, N-H),
pound
ν, cm-1
5a
5b
5c
5d
5e
7
1700, 1720
1705, 1720
1700, 1720
1700, 1725
1705, 1725
1720
1.90 (3Н, s, CH3CO2); 2.86 (3H, s, 2-CH3); 3.89 (3H, s, 3-CO2CH3);
7.16-7.20 (2H, m, H-5',6'); 7.30 (2H, t, J = 7.0, H-3,5 Ph);
7.35 (1H, t, J = 7.0, H-4 Ph); 7.38-7.40 (1H, m, H-7');
7.41 (2H, d, J = 7.0, H-2,6 Ph); 7.60-7.64 (1H, m, H-4');
8.51 (1H, s, H-4); 11.96 (1H, s, HOAc); 12.40 (1H, br. s, NH)
1.90 (3Н, s, CH3CO2); 2.84 (3H, s, 2-CH3); 3.72 (3H, s, OCH3);
3.88 (3H, s, 3-CO2CH3); 6.85 (2H, d, J = 8.5, Н Ar);
7.38 (2Н, d, J = 8.5, Н Ar); 7.17-7.21 (2H, m, H-5',6');
7.40-7.44 (1H, m, H-7'); 7.62-7.66 (1H, m, H-4'); 8.46 (1H, s, H-4);
11.96 (1H, s, HOAc); 12.38 (1H, br. s, NH)
1.90 (3Н, s, CH3CO2); 2.26 (3H, s, CH3Ar); 2.84 (3H, s, 2-CH3);
3.89 (3H, s, 3-CO2CH3); 7.09 (2Н, d, J = 8.0, Н Ar);
7.31 (2Н, d, J = 8.0, Н Ar); 7.16-7.20 (2H, m, H-5',6');
7.38-7.42 (1H, m, H-7'); 7.60-7.64 (1H, m, H-4'); 8.48 (1H, s, H-4);
11.94 (1H, s, HOAc); 12.38 (1H, br. s, NH)
1.89 (3Н, s, CH3CO2); 2.84 (3H, s, 2-CH3); 3.90 (3H, s, 3-CO2CH3);
7.18-7.20 (2H, m, H-5',6'); 7.37 (2Н, d, J = 8.0, Н Ar);
7.41 (2Н, d, J = 8.0, Н Ar); 7.41-7.45 (1H, m, H-7');
7.60-7.64 (1H, m, H-4'); 8.54 (1H, s, H-4); 11.96 (1H, s, HOAc);
12.44 (1H, br. s, NH)
1.90 (3Н, s, CH3CO2); 2.85 (3H, s, 2-CH3); 3.90 (3H, s, 3-CO2CH3);
7.17-7.21 (2H, m, H-5',6'); 7.34 (2Н, d, J = 8.0, Н Ar);
7.41-7.45 (1H, m, H-7'); 7.51 (2Н, d, J = 8.0, Н Ar);
7.60-7.64 (1H, m, H-4'); 8.54 (1H, s, H-4); 11.96 (1H, s, HOAc);
12.48 (1H, br. s, NH)
2.86 (3H, s, 2-CH3); 3.89 (3H, s, 3-CO2CH3);
7.17-7.19 (2H, m, H-5',6'); 7.30 (2H, t, J = 7.0, H-3,5 Ph);
7.35 (1H, t, J = 7.0, H-4 Ph); 7.39-7.43 (1H, m, H-7');
7.42 (2H, d, J = 7.0, H-2,6 Ph); 7.60-7.64 (1H, m, H-4');
8.51 (1H, s, H-4); 12.38 (1H, br. s, NH)
8
9
1720
2.89 (3H, s, 2-CH3); 3.08 (3H, s, 1'-CH3); 3.89 (3H, s, CO2CH3);
7.24-7.29 (4H, m, H-5',6', H-3,5 Ph); 7.33-7.37 (3H, m, H-2,4,6 Ph);
7.42-7.46 (1H, m, H-7'); 7.67-7.71 (1H, m, H-4'); 8.44 (1H, s, H-4)
1665, 3240,
3330
2.66 (3Н, s, 2-CH3); 4.57 (2H, s, NH2); 7.15-7.17 (2H, m, H-5',6');
7.27-7.33 (3H, m, H-3,4,5 Ph); 7.36-7.40 (3H, m, H-2,6 Ph, H-7');
7.59-7.63 (1H, m, H-4'); 8.02 (1H, s, H-4); 9.73 (1H, s, NHCO);
12.31 (1H, s, NH)
10
3375, 3455
2.41 (3Н, s, 2-CH3); 5.41 (2H, s, NH2);
7.13-7.18 (5H, m, H-3,4,5 Ph, H-5',6',); 7.22 (1H, s, H-4);
7.24-7.26 (2H, m, H-2,6 Ph); 7.32-7.36 (1H, m, H-7');
7.58-7.62 (1H, m, H-4'); 12.09 (1H, s, NH)
EXPERIMENTAL
1
IR spectra were taken on a UR-20 instrument for KBr tablets and H NMR spectra on a Bruker Avance
DRX 500 spectrometer (500 MHz) using DMSO-d6 and with TMS as internal standard. The course of the
reaction and purity of the compounds synthesized were monitored by TLC on Silufol UV-254 plates in the
system benzene–ethanol (9:1) and revealed using UV light. Compounds 5a-e were dried for 2 h at 40ºC and
compounds 8-10 for 5 h at 120ºC before determining the yield or carrying out elemental analysis or the
spectroscopic investigations.
Adduct of Methyl 5-(1H-benzimidazol-2-yl)-2-methyl-6-phenylnicotinate with Acetic Acid (5a).
A. A mixture of compound 1 (0.149 g, 1 mmol), compound 2a (0.236 g, 1 mmol), and compound 3
(0.252 g, 2.2 mmol) in glacial acetic acid (1 ml) was held at 120ºC for 1 h. The hot reaction mixture was diluted
945